Synthesis and Anti-HBV Activity of Novel Substituted Pyrimidine Glycosides and Their Acyclic Analogues

被引：0
|
作者：
M. A. Hawata
W. A. El-Sayed
Adel A.-H. Abdel-Rahman
机构：
[1] Menoufia University,Chemistry Department, Faculty of Science
[2] National Research Centre,Photochemistry Department
来源：
Russian Journal of General Chemistry | 2018年 / 88卷
关键词：
pyrimidines; glycosides; acyclic sugars; nucleosides; antiviral; HBV;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
New aryl substituted uracil and thiouracil glycosides are synthesized by glycosylation at N1 in the pyrimidine nucleus using glycopyranosyl halides in basic medium. In addition C-linked hydrazinyl acyclic sugar derivatives exhibiting different sugar moieties, attached at C6, are also prepared. Antiviral activity of the newly synthesized compounds is studied against Hepatitis B virus (HBV). The antiviral tests data indicated high activity of compounds 6b, 6c and 12a–12c with mild cytotoxic effects. The influence of glycosyl moieties attached to the substituted pyrimidine system in addition to the substitution at the aryl fragment on activity is discussed.
引用
收藏
页码：1734 / 1744
页数：10
相关论文
共 50 条
  • [41] Synthesis and anti-HBV activity of carbocyclic nucleoside hybrids with salient features of entecavir and aristeromycin
    Samunuri, Ramakrishnamraju
    Toyama, Masaaki
    Pallaka, Renuka Sivasankar
    Neeladri, Seshubabu
    Jha, Ashok Kumar
    Baba, Masanori
    Bal, Chandralata
    RSC MEDICINAL CHEMISTRY, 2020, 11 (05): : 597 - 601
  • [42] Study on the Chemical Constituents and anti-HBV Activity of Hypericum japonica
    Chen, Gao-yun
    Liu, Min
    Yu, Meng-bin
    Zheng, Chao
    Wei, Si-chen
    2016 3RD INTERNATIONAL CONFERENCE ON CHEMICAL AND BIOLOGICAL SCIENCES, 2016, 60
  • [43] Synthesis and anti-CVB3 activity of 4-amino acid derivative substituted pyrimidine nucleoside analogues
    Tao, Le
    Li, Yujiang
    Guo, Xiaohe
    Dong, Lihong
    Liu, Luping
    Wang, Qiang
    Yu, Xuejun
    Song, Chuanjun
    Chang, Junbiao
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (01)
  • [44] A NOVEL, SMALL ANTI-HBV COMPOUND REDUCES HBsAg AND HBV DNA BY DESTABILIZING HBV RNA
    Watanabe, Takehisa
    Hayashi, Sanae
    Nagaoka, Katsuya
    Tanaka, Yasuhito
    HEPATOLOGY, 2022, 76 : S270 - S270
  • [45] Five new secoiridoid glycosides and one unusual lactonic enol ketone with anti-HBV activity from Swertia cincta
    Jie, Xiao-Xia
    Geng, Chang-An
    Huang, Xiao-Yan
    Ma, Yun-Bao
    Zhang, Xue-Mei
    Zhang, Rong-Ping
    Chen, Ji-Jun
    FITOTERAPIA, 2015, 102 : 96 - 101
  • [46] Role of IL-2-inducible T-cell kinase in anti-HBV type Ⅰ interferon expression and anti-HBV activity
    Mengxin Lin
    Jiangfu Liu
    Zhijun Su
    Yingying Xu
    Xiuhua He
    Ruyi Guo
    Infection Control, 2024, 1 (02) : 38 - 45
  • [47] SYNTHESIS OF ANTI-RESTRICTED PYRIMIDINE ACYCLIC NUCLEOSIDES
    HSU, LY
    WISE, DS
    KUCERA, LS
    DRACH, JC
    TOWNSEND, LB
    JOURNAL OF ORGANIC CHEMISTRY, 1992, 57 (12): : 3354 - 3358
  • [48] Anti-HBV activity of in vitro combinations of tenofovir with nucleoside analogs
    Zhu, Yuao
    Qi, Xiaoping
    Delaney, William E.
    Curtis, Maria
    Miller, Michael D.
    Borroto-Esoda, Katyna
    HEPATOLOGY, 2006, 44 (04) : 253A - 253A
  • [49] Synthesis and Biological Evaluation of Acyclic Nucleotide Analogues of Bicyclic Pyrimidine Bases
    Janeba, Zlatko
    Holy, Antonin
    Snoeck, Robert
    Andrei, Graciela
    De Clercq, Eric
    Balzarini, Jan
    ANTIVIRAL RESEARCH, 2009, 82 (02) : A58 - A59
  • [50] Anti-HBV activity of retinoid drugs in vitro versus in vivo
    Birkus, Gabriel
    Snyder, Chelsea
    Jordan, Robert
    Kobayashi, Tetsuya
    Dick, Ryan
    Puscau, Vlad
    Li, Li
    Ramirez, Ricardo
    Willkom, Madeleine
    Morikawa, Yoshida
    Delaney, William E.
    Schmitz, Uli
    ANTIVIRAL RESEARCH, 2019, 169
12345